CIK 0001070081
- Large accelerated filer
PTC THERAPEUTICS, INC.
Sign in to watch- Ticker
- PTCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043416587
- Phone
- +1 908-222-7000
- Business address
- 500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
- Former names
- PTC THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,548,017
- in 9 filings, $7.5M under 10b5-1 plans
Net −$7,548,017. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-15 | Jacobson Allan Steven Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2024-02-15 | ZELDIS JEROME B Director | Grant or award | +4,000 | 14,500 | ||
| 2024-02-15 | ZELDIS JEROME B Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2024-02-15 | Young Alethia Director | Grant or award | +4,000 | 13,067 | ||
| 2024-02-15 | Young Alethia Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2024-02-15 | Reeve Emma Director | Grant or award | +4,000 | 11,200 | ||
| 2024-02-15 | Reeve Emma Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2024-02-15 | STEELE GLENN JR MD PHD Director | Grant or award | +4,000 | 14,500 | ||
| 2024-02-15 | STEELE GLENN JR MD PHD Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2024-02-15 | Smith Mary L. Director | Grant or award | +4,000 | 13,813 | ||
| 2024-02-15 | Smith Mary L. Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2024-01-30 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Sale 10b5-1 | −618 | $27.25 | $17K | 61,202 |
| 2024-01-30 | Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER | Sale 10b5-1 | −28 | $27.25 | $763 | 3,706 |
| 2024-01-30 | Boulding Mark Elliott EXEC. VP AND CLO | Sale 10b5-1 | −794 | $27.25 | $22K | 71,189 |
| 2024-01-30 | Pauwels Eric CHIEF BUSINESS OFFICER | Sale 10b5-1 | −366 | $27.25 | $10K | 44,181 |
| 2024-01-30 | Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −318 | $27.25 | $9K | 35,528 |
| 2024-01-22 | Jacobson Allan Steven Director | Option exercise 10b5-1 | +10,000 | $27.05 | $271K | 22,348 |
| 2024-01-22 | Jacobson Allan Steven Director | Sale 10b5-1 | −10,000 | $27.38 | $274K | 12,348 |
| 2024-01-22 | Jacobson Allan Steven Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −10,000 | $27.05 | $271K | 0 |
| 2024-01-09 | Utter Christine Marie SVP, FINANCE & CAO | Sale 10b5-1 | −1,653 | $29.01 | $48K | 35,846 |
Page 35 of 41 · 804 trades